Amy Deipolyi, MD New study suggests that these specialists can perform the procedure safely and accurately. NEW ORLEANS—Transrectal ultrasound (TRUS)-guided prostate fiducial marker placement appears ...

Prostate cancer researchers at Sydney's Garvan Institute, supported by the Cancer Institute NSW, have found a new marker for identifying aggressive prostate cancers. Many men with prostate cancer have ...

Improved screening accuracy in calculating a man’s risk of prostate cancer is achievable using results from two blood markers rather than one alone, said the researchers behind a new study. It is well ...

Calculating a person's risk of developing prostate cancer using results from two blood markers would improve the accuracy of screening for the disease, reports a new study led by a UCL researcher.

LONDON (Reuters) - A popular baldness drug taken by more than 4 million men worldwide can mask an important marker used in screening tests to detect prostate cancer, scientists said on Monday.

SAN FRANCISCO, May 9 – Findings presented at the annual meeting of the American Urological Association (AUA) indicate that prostate cancer could be detected as many as five years earlier than it is ...

A novel endoscopically inserted marker might help improve the radiologic assessment of esophagogastric cancers and allow for image-guided radiotherapy (IGRT), according to a small phase 2 pilot study.

A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study funded by Cancer Research UK. Cancer Research UK-funded scientists, ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. For men with prostate cancer, even those with the early-stage type, the ...

Mar. 23 -- FRIDAY, June 1 (HealthDay News) -- A protein that is used as a marker of heart disease may also predict survival odds and response to chemotherapy for men with advanced prostate cancer.

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both hormone-sensitive and castration-resistant patients. The study published ...